Mucopolysaccharidosis or mukolipidose type iii Treff i utvalgte kilder: [Skjul boksen]
  1. Frambu
    -
    www.frambu.no/mukolipidose-ii-og-iii
    /
    ... på våre nettsider) Mukolipidose type II (ML II) Mukolipidose type III (ML III) Mukolipidose type IV (ML IV, ikke ... våre nettsider) Mukolipidose type II (ML II) og mukolipidose type III (ML III) er ulike uttrykk for en arvelig, ...
  2. Frambu
    -
    www.frambu.no/diagnoser
    /
    ... Facioscapulohumeral muskeldystrofi Infantil nevroaxonal dystrofi Spongiform leukoencefalopati CoPAN Mukolipidose type III ANAD MPAN Spielmeyer-Vogts sykdom Steinerts sykdom Progeria ...
  3. Frambu
    -
    www.frambu.no/mukolipidose-i-sialidose
    /
    ... II, omtalt et annet sted på våre nettsider) Mukolipidose type III (ML III, omtalt et annet sted på våre nettsider) Mukolipidose type IV (ML IV, ikke omtalt på våre nettsider) ...
  4. Frambu
    -
    www.frambu.no/sanfilippos-sykdom
    /
    Sanfilippos sykdom (mukopolysakkaridose type III, MPS III) er en arvelig, medfødt stoffskiftesykdom som skyldes mangelfull nedbrytning av mukopolysakkaridet heparansulfat, med derav følgende opphopning ...
  5. Frambu
    -
    www.frambu.no
    /
    ... Facioscapulohumeral muskeldystrofi Infantil nevroaxonal dystrofi Spongiform leukoencefalopati CoPAN Mukolipidose type III ANAD MPAN Spielmeyer-Vogts sykdom Steinerts sykdom Progeria ...
  6. bmj-bestpractice
    -
    https://bestpractice.bmj.com/topics/en-us/1021/pdf/1021.pdf
    /
    ... hyaluronidase deficiency). Other • Pompe disease/glycogen storage disease type ... II/III, IV, Danon disease, Wolman disease, lysosomal transport defects ( ...
  7. bmj-bestpractice
    -
    https://bestpractice.bmj.com/topics/en-gb/1021/pdf/1021.pdf
    /
    ... deficiency). Other • Pompe's disease/glycogen storage disease type 2 ... deficiency, mucolipidosis II/III, IV, Danon's disease, Wolman's disease, lysosomal ...
  8. bmj-bestpractice
    -
    https://bestpractice.bmj.com/topics/en-gb/1021/management-approach
    /
    ... been approved for type VII (Sly syndrome). Phase III trials with vestronidase alfa are ongoing. [97] NHS; National Institute for Health Research (NIHR). NIHR Innovation Observatory evidence briefing. Vestronidase alfa (UX-003) for mucopolysaccharidosis type VII (MPS 7; Sly syndrome) NIHRIO (HSRIC) ID: ...
  9. bmj-bestpractice
    -
    https://bestpractice.bmj.com/topics/en-gb/1021/treatment-algorithm
    /
    ... been approved for type VII (Sly syndrome). Phase III trials with vestronidase alfa are ongoing. [97] NHS; National Institute for Health Research (NIHR). NIHR Innovation Observatory evidence briefing. Vestronidase alfa (UX-003) for mucopolysaccharidosis type VII (MPS 7; Sly syndrome) NIHRIO (HSRIC) ID: ...
  10. bmj-bestpractice
    -
    https://bestpractice.bmj.com/topics/en-us/1021/management-approach
    /
    ... been approved for type VII (Sly syndrome). Phase III trials with vestronidase alfa are ongoing. [104] NHS; National Institute for Health Research (NIHR). NIHR Innovation Observatory evidence briefing. Vestronidase alfa (UX-003) for mucopolysaccharidosis type VII (MPS 7; Sly syndrome) NIHRIO (HSRIC) ID: ...
forrige · 1 · 2 · 3 · neste